Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,299 | 1,027 | 98.1% |
| Education | $290.48 | 14 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,928 | 125 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,301 | 78 | $0 (2024) |
| Lilly USA, LLC | $1,276 | 88 | $0 (2024) |
| PFIZER INC. | $1,215 | 94 | $0 (2024) |
| Amgen Inc. | $1,090 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,030 | 68 | $0 (2024) |
| ABBVIE INC. | $975.00 | 70 | $0 (2024) |
| Merck Sharp & Dohme LLC | $971.16 | 80 | $0 (2024) |
| Allergan, Inc. | $566.18 | 59 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $520.24 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,798 | 95 | Novo Nordisk Inc ($178.69) |
| 2023 | $1,371 | 77 | GlaxoSmithKline, LLC. ($182.57) |
| 2022 | $1,710 | 106 | ABBVIE INC. ($221.80) |
| 2021 | $2,348 | 146 | Novo Nordisk Inc ($427.91) |
| 2020 | $1,860 | 126 | GlaxoSmithKline, LLC. ($239.48) |
| 2019 | $1,931 | 141 | Novo Nordisk Inc ($227.68) |
| 2018 | $2,193 | 174 | Novo Nordisk Inc ($303.43) |
| 2017 | $2,377 | 176 | Merck Sharp & Dohme Corporation ($260.21) |
All Payment Transactions
1,041 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Vaccines | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: UROLOGY | ||||||
| 10/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Biological | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 833 | 1,124 | $246,988 | $92,826 |
| 2022 | 16 | 1,169 | 1,486 | $317,655 | $117,067 |
| 2021 | 13 | 1,061 | 1,320 | $245,423 | $110,000 |
| 2020 | 16 | 1,094 | 1,275 | $216,526 | $90,495 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 514 | $141,350 | $47,783 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 112 | 112 | $31,360 | $14,987 | 47.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 119 | 125 | $20,520 | $8,968 | 43.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $9,945 | $4,795 | 48.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 29 | $12,905 | $4,578 | 35.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 128 | 134 | $8,485 | $4,295 | 50.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 81 | 83 | $8,798 | $3,547 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 60 | $11,700 | $3,095 | 26.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $985.00 | $608.95 | 61.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $770.00 | $132.55 | 17.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 17 | $170.00 | $37.40 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 285 | 558 | $163,750 | $50,097 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 177 | 177 | $48,548 | $24,439 | 50.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 122 | 126 | $20,424 | $8,610 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 129 | $25,700 | $8,247 | 32.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 23 | 26 | $11,545 | $4,206 | 36.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 126 | 130 | $5,200 | $4,088 | 78.6% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 89 | 91 | $9,646 | $3,807 | 39.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 73 | 73 | $7,738 | $3,029 | 39.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $6,600 | $2,594 | 39.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $5,040 | $2,480 | 49.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 12 | 12 | $4,288 | $2,119 | 49.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $4,250 | $1,845 | 43.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $760.00 | $601.27 | 79.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,490 | $531.14 | 35.6% |
About Dr. Brad Friedmann, D.O
Dr. Brad Friedmann, D.O is a Family Medicine healthcare provider based in Langhorne, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922019363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brad Friedmann, D.O has received a total of $15,589 in payments from pharmaceutical and medical device companies, with $1,798 received in 2024. These payments were reported across 1,041 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($15,299).
As a Medicare-enrolled provider, Friedmann has provided services to 4,157 Medicare beneficiaries, totaling 5,205 services with total Medicare billing of $410,388. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Langhorne, PA
- Active Since 08/11/2006
- Last Updated 05/19/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922019363
Products in Payments
- FARXIGA (Drug) $696.67
- TRELEGY ELLIPTA (Drug) $678.79
- TRULICITY (Drug) $621.22
- VRAYLAR (Drug) $517.99
- JANUVIA (Drug) $513.05
- Ozempic (Drug) $447.55
- Aimovig (Biological) $367.24
- CHANTIX (Drug) $351.98
- JARDIANCE (Drug) $339.32
- Prolia (Biological) $301.59
- Saxenda (Drug) $301.28
- UBRELVY (Drug) $292.80
- XIFAXAN (Drug) $281.86
- REXULTI (Drug) $273.39
- ANORO (Drug) $261.63
- ELIQUIS (Drug) $246.60
- Tymlos (Biological) $241.12
- NURTEC ODT (Drug) $238.17
- EMGALITY (Drug) $235.49
- LINZESS (Drug) $231.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Langhorne
Michael Smith, D.o, D.O
Family Medicine — Payments: $4,061
Matthew Kulka, D.o, D.O
Family Medicine — Payments: $3,486
Robert Danoff, D.o, D.O
Family Medicine — Payments: $3,081
Christina Mcadams, Md, MD
Family Medicine — Payments: $3,022
Dr. Michael Krevolin, D.o, D.O
Family Medicine — Payments: $2,260
Dr. Lisa Ducker, Do, DO
Family Medicine — Payments: $1,686